These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2725853)

  • 1. [D-TRP11]-neurotensin, unlike alpha-flupenthixol, may not block amphetamine-induced hyperactivity in rats.
    Sahgal A; Keith AB; Lloyd S; Edwardson JA
    Neuropharmacology; 1989 Mar; 28(3):283-9. PubMed ID: 2725853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-flupenthixol-induced hyperactivity by chronic dosing in rats.
    Sahakian BJ; Robbins TW; Iversen SD
    Eur J Pharmacol; 1976 May; 37(1):169-78. PubMed ID: 945170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats.
    Bauco P; Rompré PP
    Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locomotor effects of [D-Trp11]neurotensin and dopamine transmission in rats.
    Nouel D; Costentin J
    Eur J Pharmacol; 1994 Mar; 254(3):263-9. PubMed ID: 8013561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation.
    Koob GF; Swerdlow N; Seeligson M; Eaves M; Sutton R; Rivier J; Vale W
    Neuroendocrinology; 1984 Nov; 39(5):459-64. PubMed ID: 6096752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine.
    Skoog KM; Cain ST; Nemeroff CB
    Neuropharmacology; 1986 Jul; 25(7):777-82. PubMed ID: 3748325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
    Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
    J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
    Hertel P; Byskov L; Didriksen M; Arnt J
    Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution to the pharmacology of a novel neuroleptic drug: flupenthixol (author's transl)].
    van den Driessche J
    Arzneimittelforschung; 1977; 27(11):2121-5. PubMed ID: 580012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor hypoactivity induced by neurotensin and related peptides in mice.
    Meisenberg G; Simmons WH
    Pharmacol Biochem Behav; 1985 Feb; 22(2):189-93. PubMed ID: 3983212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of d-amphetamine, chlordiazepoxide and alpha-flupenthixol on food-reinforced tracking of a visual stimulus by rats.
    Evenden JL; Robbins TW
    Psychopharmacology (Berl); 1985; 85(3):361-6. PubMed ID: 3923522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
    Boules M; Warrington L; Fauq A; McCormick D; Richelson E
    Eur J Pharmacol; 2001 Aug; 426(1-2):73-6. PubMed ID: 11525773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of neurotensin in the open field: structure-activity studies.
    Elliott PJ; Chan J; Parker YM; Nemeroff CB
    Brain Res; 1986 Sep; 381(2):259-65. PubMed ID: 3756503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the rat.
    Stoessl AJ; Szczutkowski E
    Brain Res; 1991 Sep; 558(2):289-95. PubMed ID: 1685934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11]neurotensin during the semichronic intracerebroventricular infusion of the peptide in rats.
    Dubuc I; Pain C; Suaudeau C; Costentin J
    Peptides; 1994; 15(2):303-7. PubMed ID: 8008636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
    Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
    J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the inhibitory effect of [D-Trp11]-NT toward some biological actions of neurotensin in rats.
    Rioux F; Kérouac R; St-Pierre S
    Neuropeptides; 1983 Jul; 3(5):345-54. PubMed ID: 6194472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ; Nemeroff CB
    Neurosci Lett; 1986 Jul; 68(2):239-44. PubMed ID: 3748452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.